Effect | Increase |
Trial Design | Non-randomized controlled trial |
Trial Length | 2-4 Weeks |
Number of Subjects | 6 |
Sex | Both Genders |
Age Range | 45-64 |
Body Types | Overweight |
6 persons with type II diabetes subject to Vanadium treatment for 3 weeks at 100mg daily improved glucose tolerance and insulin sensitivity in response to glucose by enhancing the actions of insulin; these persisted for 2 weeks after cessation of vanadium.
A trend to reduce triglycerides was noted, but failed to be significant.